News & Blog

January 13, 2025 | Press Release
David P. King joins Truvian’s Advisory Board
January 13, 2025 | Press Release
Aspen Neuroscience Announces Completion of First and Second Cohorts in ASPIRO Phase 1/2a Trial for Parkinson’s Disease
December 11, 2024 | Press Release
Truvian Health Appoints Dr. Tina Nova to its Board of Directors
December 02, 2024 | Press Release
SonoThera Presents New Data at the American Society of Hematology (ASH) Annual Meeting Demonstrating the Potential of Targeted, Ultrasound-Mediated Gene Delivery to Liver
November 14, 2024 | Press Release
Nobias Therapeutics Announces Strategic Focus and New Leadership
November 12, 2024 | Press Release
Aspen Neuroscience Chief Financial Officer Kameel Farag to Present at UBS Global Healthcare Conference
November 06, 2024 | In The News
In the News: Biotechnology’s Security Frontier: Navigating Innovation and Safeguards
November 01, 2024 | Blog Post
Q3 2024 MEC Newsletter
October 19, 2024 | Press Release
Study PRO-101: Experience implementing an ALS community advisory board in early phase drug development
October 08, 2024 | In The News
Endpoints News Honors Aspen Neuroscience Co-Founder Dr. Jeanne Loring in “20 Women Breaking New Ground”